Synchroneuron raises $6M Series A; Rib-X scores $3M milestone; smoking makes you stupid;

@FierceBiotech: GSK will cut 3 research units, add 4 as R&D productivity swells. Witty pronounced himself satisfied. Article | Follow @FierceBiotech

@JohnCFierce: GSK completes tally on DPUs: 3 gone, 4 added, 8 get new chiefs. Productivity up. Seem pretty happy with the direction. News | Follow @JohnCFierce

@FierceMedDev: Consumers Union pushes to improve medical device safety: Story | Follow @FierceMedDev

> Waltham, MA-based Synchroneuron has rounded up $6 million in a Series A designed to support its work on a new treatment for Tardive dyskinesia. Story

> Rib-X Pharmaceuticals says it snagged a $3 million milestone from Sanofi. Release

> Five Prime Therapeutics says it will officially make Lewis Williams its CEO. News

Pharma News

@FiercePharma: Big Pharma needs to enroll at Hogwarts, the FT says. Article | Follow @FiercePharma

> Daiichi shops India for bolt-on deals, ET says. More

> What can Big Pharma learn from an NYT bestseller? Item

> Reuters: Nestle leads pack of bidders for Pfizer nutrition unit. Story

> Bayer CEO: Shortsighted price cuts lead to long-term pain. Article

> How do the 12 priciest drugs in the U.S. stack up? Piece

Research News

> CA stem cell researchers planning for life without state funding. Item

> In a breakthrough, scientists blame tau proteins for spreading Alzheimer's. More

> Silver, slayer of werewolves, explored as cancer fighter. Article

> Walnuts slow prostate cancer tumor growth in mice. Story

> Can't get enough donuts? A specific gene variation may explain why. More

Manufacturing News

> FDA report shows deep problems at closed Novartis Consumer Health plant. More

> Merck's manufacturing information not trade secrets, court rules. News

> AstraZeneca faces resistance to job cuts on home turf. Story

> Dishman set to bail on API manufacturing in once-promising China. Article

> Smith & Nephew eliminating 800 jobs, restructuring already felt in Memphis. News

And Finally... Smoking isn't just stupid in and of itself. It also makes you dumber over time, according to a new study. Report

Suggested Articles

Werewolf is launching with $56 million and an approach that can cut through the toxic effects that have limited certain cancer-killing agents.

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.